
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
What should we do about smallpox immunization? Report card: The quality of health care. Knowing what's in a name: New rules for labeling "organic" food. Eye on Washington






